Dr. Arash Mohaghegh Davanian , DO
Ophthalmology โข Dallas, TX
9600 N Central Expy Ste 300
Dallas, TX 752315025
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on May 17, 2016; this date does not establish years in practice.
-
Published CMS data list 2,481 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 587 service units.
- 99214 โ Established patient outpatient office visit: 523 service units.
- 92083 โ Exam of visual field with extended testing: 258 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 4,461 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Latanoprost โ 1,200 prescription fills, including refills.
- Dorzolamide-Timolol (Dorzolamide Hcl/Timolol Maleat) โ 832 prescription fills, including refills.
- Brimonidine Tartrate โ 432 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 25 records in the table ยท Guide: How to read Medicare Part D prescriber data
-
Close to the middle for Medicare Part B services among clinicians listed under Ophthalmology in Dallas, TX (2024, 100 clinicians with data). Median for this group: 2,161. Middle half: 917 to 3,903.
More Medicare Part B services than 60% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 30 in 2020 to 2,481 in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2020โ2024.
Practice Location & Contact Primary Location
9600 N Central Expy Ste 300
Dallas, TX 752315025
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 1 group name: Glaucoma Center Of Texas, Pa. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Nova Southeastern College Of Osteo Medicine
2016
What Public CMS Data Show
Ophthalmology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
401 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $213,771 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $158,619 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
8,213 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$254,509 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $1,121.14 across 24 records.
By nature of payment
- Food and Beverage: $1,121.14 across 24 records.
Reporting-company totals (3 largest of 4)
- ABBVIE INC.: $471.15 across 15 records.
- Alcon Vision LLC: $405.65 across 6 records.
- Glaukos Corporation: $184.74 across 1 record.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
10 years (graduated 2016)
CMS Doctors and Clinicians data list 2016 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2016
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Davanian has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Davanian as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Dallas and Texas
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Close to the middle for clinicians listed under Ophthalmology in Dallas, TX (2024, 100 clinicians with data). Median for this group: 2,161. Middle half: 917 to 3,903.
More Medicare Part B services than 60% of clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: 1,764. Middle half: 751 to 3,589.
Medicare-allowed amount
Close to the middle for clinicians listed under Ophthalmology in Dallas, TX (2024, 100 clinicians with data). Median for this group: $238,030. Middle half: $99,956 to $431,963.
Close to the middle for clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $211,752. Middle half: $85,606 to $415,016.
Paid by Medicare
Close to the middle for clinicians listed under Ophthalmology in Dallas, TX (2024, 100 clinicians with data). Median for this group: $171,634. Middle half: $69,400 to $316,481.
Close to the middle for clinicians listed under Ophthalmology in Texas (2024, 992 clinicians with data). Median for this group: $151,943. Middle half: $60,170 to $302,740.
Medicare Part D prescriptions
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Dallas, TX (2024, 117 clinicians with data). Median for this group: 918. Middle half: 394 to 1,912.
More Part D prescriptions than 90% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: 905. Middle half: 327 to 2,157.
Part D drug cost
A higher Part D drug cost than 80% of clinicians listed under Ophthalmology in Dallas, TX (2024, 117 clinicians with data). Median for this group: $68,477. Middle half: $14,401 to $187,328.
A higher Part D drug cost than 75% of clinicians listed under Ophthalmology in Texas (2024, 1,065 clinicians with data). Median for this group: $73,797. Middle half: $14,089 to $240,265.
157 active clinicians are listed under Ophthalmology with a practice address in Dallas, TX (1,517 in Texas).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Dallas
1.3% of these 157 clinicians have the CMS telehealth indicator.
69.4% of these 157 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services increased 8170% from 30 in 2020 to 2,481 in 2024.
- 2020: 30
- 2021: 507
- 2022: 1,332
- 2023: 1,547
- 2024: 2,481
-
Medicare-allowed amount
Medicare-allowed amount increased 6001% from $3,504 in 2020 to $213,771 in 2024.
- 2020: $3,504
- 2021: $45,134
- 2022: $151,895
- 2023: $150,693
- 2024: $213,771
-
Paid by Medicare
Paid by Medicare increased 5550% from $2,807 in 2020 to $158,619 in 2024.
- 2020: $2,807
- 2021: $35,528
- 2022: $114,286
- 2023: $111,343
- 2024: $158,619
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 1112% from 368 in 2020 to 4,461 in 2024.
- 2020: 368
- 2021: 1,221
- 2022: 2,221
- 2023: 4,012
- 2024: 4,461
-
30-day fills
30-day fills increased 1299% from 587 in 2020 to 8,213 in 2024.
- 2020: 587
- 2021: 2,022
- 2022: 3,952
- 2023: 7,144
- 2024: 8,213
-
Part D drug cost
Part D drug cost increased 984% from $23,473 in 2020 to $254,509 in 2024.
- 2020: $23,473
- 2021: $103,456
- 2022: $210,499
- 2023: $386,171
- 2024: $254,509
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $553.21 in 2021 to $1,121.14 in 2025.
- 2021: $553.21
- 2022: $1,075.52
- 2023: $1,141.87
- 2024: $576.73
- 2025: $1,121.14
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 โ December 31, 2025): 24 records totaling $1,121.14.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
HYDRUS Microstent | General | $188.80 |
| Glaukos Corporation |
Food and Beverage
Cash or cash equivalent
|
iStent infinite | General | $184.74 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Clareon PanOptix Pro | General | $130.75 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $114.31 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $54.53 |
| Sight Sciences, Inc. |
Food and Beverage
In-kind items and services
|
OMNI SURGICAL SYSTEM | General | $41.68 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $35.26 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $33.90 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $33.18 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $32.68 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Rocklatan | General | $31.90 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $31.65 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Rocklatan | General | $26.45 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $25.84 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $25.31 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $24.82 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
EYSUVIS | General | $22.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
XEN GLAUCOMA TREATMENT SYSTEM | General | $19.83 |
| Sight Sciences, Inc. |
Food and Beverage
In-kind items and services
|
OMNI SURGICAL SYSTEM | General | $17.92 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
DURYSTA | General | $15.98 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $8.80 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $7.56 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
LUMIGAN | General | $7.50 |
| Alcon Vision LLC |
Food and Beverage
In-kind items and services
|
Rocklatan | General | $5.75 |
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2019โ2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2020โ2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
587 | 318 | $54.77 | $15.94 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
523 | 315 | $325.00 | $124.68 |
|
92083
Exam of visual field with extended testing
|
258 | 244 | $205.00 | $61.35 |
|
92133
Imaging of optic nerve
|
219 | 216 | $140.00 | $34.94 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
189 | 134 | $220.00 | $88.50 |
|
92020
Exam of the internal drainage system of eye
|
120 | 117 | $85.00 | $26.50 |
|
92136
Measurement of corneal curvature and depth of eye
|
99 | 39 | $185.40 | $25.73 |
|
99204
New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more
|
99 | 99 | $500.00 | $162.33 |
|
92250
Photography of the retina
|
98 | 98 | $220.00 | $35.74 |
|
76514
Ultrasound scan of cornea to determine thickness
|
96 | 96 | $45.00 | $10.31 |
|
65855
Laser repair to improve eye fluid flow
|
54 | 40 | $1065.00 | $237.19 |
|
66984
Removal of cataract with insertion of prosthetic lens
|
52 | 40 | $2500.00 | $392.46 |
|
92025
Ct scan of cornea
|
37 | 37 | $155.00 | $34.24 |
|
65820
Incision to improve eye fluid flow
|
25 | 24 | $1500.00 | $806.04 |
|
66180
Creation of shunt to improve eye fluid flow using tissue graft
|
13 | 12 | $3600.00 | $1110.29 |
|
66821
Removal of recurring cataract in lens capsule using a laser
|
12 | 11 | $1050.00 | $303.45 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Latanoprost | Latanoprost | 1,200 | 56,710 | $7,768.49 | 357 |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 832 | 54,581 | $9,674.17 | 297 |
| Brimonidine Tartrate | Brimonidine Tartrate | 432 | 26,924 | $9,033.74 | 178 |
| Timolol Maleate | Timolol Maleate | 346 | 22,646 | $4,298.87 | 121 |
| Prednisolone Acetate | Prednisolone Acetate | 338 | 13,669 | $15,714.43 | 200 |
| Ofloxacin | Ofloxacin | 186 | 4,097 | $1,900.00 | 161 |
| Dorzolamide Hcl | Dorzolamide Hcl | 180 | 12,430 | $3,775.35 | 78 |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 105 | 2,612 | $2,637.47 | 88 |
| Lumigan | Bimatoprost | 92 | 5,061 | $42,556.60 | 39 |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 86 | 5,462 | $14,522.12 | 35 |
| Travoprost | Travoprost | 80 | 4,155 | $9,157.31 | 24 |
| Pilocarpine Hcl | Pilocarpine Hcl | 71 | 6,780 | $4,118.83 | 65 |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 69 | 2,622 | $33,341.49 | 23 |
| Rhopressa | Netarsudil Mesylate | 61 | 2,541 | $24,719.90 | 13 |
| Atropine Sulfate | Atropine Sulfate | 49 | 2,208 | $1,996.51 | 42 |
| Simbrinza | Brinzolamide/Brimonidine Tart | 45 | 2,481 | $11,616.63 | 18 |
| Brinzolamide | Brinzolamide | 44 | 2,572 | $6,491.06 | 12 |
| Combigan | Brimonidine Tartrate/Timolol | 43 | 2,794 | $17,911.46 | 17 |
| Difluprednate | Difluprednate | 40 | 758 | $3,167.39 | 25 |
| Acetazolamide | Acetazolamide | 36 | 381 | $735.17 | 17 |
| Loteprednol Etabonate | Loteprednol Etabonate | 35 | 652 | $3,909.82 | 19 |
| Alphagan P | Brimonidine Tartrate | 31 | 1,706 | $11,271.11 | 13 |
| Vyzulta | Latanoprostene Bunod | 26 | 1,206 | $9,857.26 | โ |
| Valacyclovir | Valacyclovir Hcl | 21 | 500 | $1,024.10 | โ |
| Lotemax Sm | Loteprednol Etabonate | 13 | 346 | $3,309.84 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2022-02-08NUCC Taxonomy Code: 207W00000X
An ophthalmologist has the knowledge and professional skills needed to provide comprehensive eye and vision care. Ophthalmologists are medically trained to diagnose, monitor and medically or surgically treat all ocular and visual disorders. This includes problems affecting the eye and its component structures, the eyelids, the orbit and the visual pathways. In so doing, an ophthalmologist prescribes vision services, including glasses and contact lenses.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - OPHTHALMOLOGY
I20210609002391
TX
3577837715
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Glaucoma Center Of Texas, Pa
9600 N Central Expressway, Dallas, TX 75231
Phone: 2147393900
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Ophthalmology
Doctor of Medicine (M.D.)
Ophthalmology
Doctor of Osteopathic Medicine (D.O.)
Ophthalmology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 9600 N CENTRAL EXPY STE 300, DALLAS, TX 752315025 (Tel: 2147393900)
Ophthalmology (license number reported to NPPES: TX S8700)
Registered at 9600 N CENTRAL EXPY, STE 300, DALLAS, TX 752315025 (Tel: 6153223000)
Registered at 3601 THE VANDERBILT CLINIC, NASHVILLE, TN 372321333 (Tel: 6153223000)
Registered at 719 THOMPSON LN STE 30330, NASHVILLE, TN 372044701 (Tel: 6153223000)
NPI status registered as active in NPPES database
Registered at 1120 15TH ST # BA-2720, AUGUSTA, GA 309121333 (Tel: 7067211160)
Registered at 1120 15TH ST # BA-2720, AUGUSTA, GA 309120004 (Tel: (706) 721-1160)
Recorded as ARASH DAVANIAN, D.O.
Student in an Organized Health Care Education/Training Program
NPI status registered as active in NPPES database
Registered at 817 PRINCETON AVE SW, POB II; SUITE 106, BIRMINGHAM, AL 352111333 (Tel: 2057837663)
Registered at 817 PRINCETON AVE SW, POB II; SUITE 106, BIRMINGHAM, AL 352111333
Recorded as ARASH DAVANIAN, D.O.
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Ophthalmology Specialists in Dallas
- Dr. Oluwatosin Smith, MD
- Dr. Jeffrey Robertson, MD
- Dr. Heather Winslow, MD
- Dr. Vamsee Neerukonda, MD
- Dr. Karen Saland, MD
- Dr. Gary Fish, MD
Mailing Address
9600 N Central Expy, Ste 300
Dallas, TX 752315025
Phone: 2147393900